Cheng-Yu Chen

Cheng-Yu Chen

Auto-generated profile, based on publicly available information

Cheng-Yu Chen

X-Dimension Center for Medical Research and Translation, China Medical University Hospital, Taichung, 404332, Taiwan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2023 in Ceramics International
Verified
Journal Article
Closed access
CWChen-Ying Wang
Chen-Ying Wang
CCCheng-Yu Chen
Cheng-Yu Chen
KCKun-Hao Chen
Kun-Hao Chen
YLYen-Hong Lin
Yen-Hong Lin
TYTzu-Peng Yeh
Tzu-Peng Yeh
Ming-You ShieMing-You Shie
Ming-You Shie

19 July 2023 in Materials Today Bio
Verified
Journal Article
Open access
TLTsung-Li Lin
Tsung-Li Lin
YLYen-Hong Lin
Yen-Hong Lin
ALAlvin Kai-Xing Lee
Alvin Kai-Xing Lee
TKTing-You Kuo
Ting-You Kuo
CCCheng-Yu Chen
Cheng-Yu Chen
Ming-You ShieMing-You Shie
Ming-You Shie
The development of surface modification techniques has brought about a major paradigm shift in the clinical applications of bone tissue regeneration. Biofabrication strategies enable the creation of scaffolds with specific microstructural environments and biological components. Lithium (Li) has been reported to exhibit anti-inflammatory, osteogenic, and chondrogenic properties by promoting several intracellular signaling pathways. Currently, research focuses on fabricating scaffolds with simultaneous dual bioactivities to enhance osteochondral regeneration. In this study, we modified the surface of calcium silicate (CS) scaffolds with Li using a simple immersion technique and evaluated their capabilities for bone regeneration. The results showed that Li ions could be easily coated onto the surfaces of CS scaffolds without affecting the microstructural properties of CS itself. Furthermore, the modifications did not affect the printing capabilities of the CS, and porous scaffolds could be fabricated via extrusion. Moreover, the presence of Li improved the surface roughness and hydrophilicity, thus leading to enhanced secretion of osteochondral-related regeneration factors, such as alkaline phosphatase (ALP), bone sialoprotein (BSP), and collagen II (Col II) proteins. Subsequent in vivo studies, including histological and micro-CT analyses, confirmed that the Li-modified CS scaffolds promoted osteochondral regeneration. The transcriptome analysis suggested that the enhanced osteochondrogenic capabilities of our scaffolds were influenced by paracrine exosomes. We hope this study will inspire further research on osteochondral regeneration.

29 January 2024 in Ceramics International
Verified
Journal Article
Closed access
YTYi-Ling Tsai
Yi-Ling Tsai
JLJian-Jr Lee
Jian-Jr Lee
CWChen-Ying Wang
Chen-Ying Wang
YLYen-Hong Lin
Yen-Hong Lin
CCCheng-Yu Chen
Cheng-Yu Chen
Ming-You ShieMing-You Shie
Ming-You Shie

6 September 2025 in Materials Today Bio
Verified
Journal Article
Open access
CCCheng-Yu Chen
Cheng-Yu Chen
JLJian-Jr Lee
Jian-Jr Lee
YLYen-Hong Lin
Yen-Hong Lin
TKTing-You Kuo
Ting-You Kuo
DCDer-Yang Cho
Der-Yang Cho
Ming-You ShieMing-You Shie
Ming-You Shie
Current therapeutic strategies for bone defects, including autografts, allografts, and conventional biomaterial scaffolds, are limited by donor site morbidity, immune rejection, and insufficient vascularization. Moreover, the complex inflammatory microenvironment in bone defects often impairs healing outcomes, necessitating the development of advanced biomaterials with enhanced immunomodulatory and regenerative capabilities. This study investigates the therapeutic potential of extracellular vesicles derived from Astragalus-modified calcium silicate (AstCS)-stimulated M2 macrophages (AstCSM2EVs) in bone regeneration. The AstCSM2EVs demonstrated superior immunomodulatory capabilities by effectively polarizing macrophages toward the M2 phenotype, characterized by significant downregulation of pro-inflammatory cytokines (IL-1β, TNF-α) and concurrent upregulation of anti-inflammatory mediators (IL-4, IL-10). Notably, AstCSM2EVs exhibited enhanced angiogenic potential, evidenced by increased endothelial tube formation and elevated VEGF secretion, while simultaneously promoting osteogenic differentiation of mesenchymal stem cells through upregulated expression of key markers including ALP, BSP, and OC. Mechanistic investigations revealed that AstCSM2EVs modulated these regenerative processes primarily through miR-218-5p-mediated regulation of multiple signaling pathways, including NOD-like receptor and ECM-receptor interaction pathways. In a rabbit femoral defect model, local administration of AstCSM2EVs significantly enhanced bone regeneration, demonstrated by increased bone volume fraction and improved trabecular architecture, while effectively suppressing local inflammation. These findings establish AstCSM2EVs as a promising therapeutic agent for bone regeneration, highlighting their multifaceted roles in immunomodulation, angiogenesis, and osteogenesis. This research introduces an innovative approach that combines extracellular vesicles (EV) with immunomodulatory tissue engineering strategies to improve the treatment of bone defects.